Luxembourg Offers Free Nasal Flu Vaccine to Children

Children ages 2 to 17 in Luxembourg can receive free influenza vaccines through a nasal spray under a new measure introduced by the country's Health Ministry on Monday, October 12, 2026. The option is available during consultations with general practitioners or pediatricians as part of a broader campaign to prevent respiratory infections ahead of winter.

The ministry's third annual prevention campaign addresses influenza, COVID-19, respiratory syncytial virus (RSV), whooping cough and pneumococcal pneumonia. The initiative comes as authorities report renewed COVID-19 activity at the beginning of autumn and seasonal respiratory viruses begin circulating.

According to the Health Ministry, vaccination remains the most effective way to prevent severe illness and protect vulnerable people. Preventive measures to limit transmission also remain important during the respiratory virus season.

The nasal spray is a new option for children this year and is provided free of charge. It allows eligible children to receive influenza vaccination without an injection during an appointment with their doctor.

The ministry says the nasal vaccine is intended to make vaccination more acceptable to young children while providing effective protection. However, the nasal spray is not the only option available to families.

Children can still receive the standard injectable influenza vaccine if they or their parents prefer an injection, if the child has a contraindication to the nasal vaccine, or if supplies of the nasal formulation run out.

In these circumstances, the injectable vaccine will be available free of charge at pharmacies with a medical prescription, following the arrangement used during the 2025-2026 winter season, according to the ministry.

The campaign also highlights the risks of respiratory syncytial virus, which is commonly associated with bronchiolitis in infants and young children but can cause serious complications in older adults.

According to the Health Ministry, RSV can damage the lungs, worsen existing heart or lung conditions and cause acute respiratory distress. Severe infections may require hospitalization and can sometimes result in death.

A vaccine against RSV is available for older adults at increased risk of complications. The ministry covers the cost for people aged 75 and older, particularly those living in residential care facilities.

People aged 65 and older who have underlying conditions that increase their risk of severe RSV infection are also eligible for coverage. The ministry recommends consulting a primary care physician to determine eligibility for vaccination.